Dengue fever is a global concern - we urge the United Nations to designate a World Dengue Day at its General Assembly in September 2019
Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016by GBD 2016 Brazil Collaborators published in The Lancet
Oral Antibiotic Treatment of Mice Exacerbates the Disease Severity of Multiple Flavivirus Infectionsby Thackray LB et al.
Treatment with antibiotics depletes the gut microbiota in mice, making them more susceptible to infection by dengue, zika and west nile virus.
Dengue is a mosquito-borne disease that threatens over half of the world’s population. Despite being endemic to more than 100 countries, government-led efforts and tools for timely identification and tracking of new infections are still lacking in many affected areas. Multiple methodologies that leverage the use of Internet-based data sources have been proposed as a way to complement dengue surveillance efforts. Among these, dengue-related Google search trends have been shown to correlate with dengue activity. We extend a methodological framework, initially proposed and validated for flu surveillance, to produce near real-time estimates of dengue cases in five countries/states: Mexico, Brazil, Thailand, Singapore and Taiwan. Our result shows that our modeling framework can be used to improve the tracking of dengue activity in multiple locations around the world.
The number of publications about dengue fever has grown strongly since 1960 reflecting strong growth in the number of global cases.
World Health Organization (WHO) recommendations on the use of dengue vaccine
Dengue vaccination would be cost-effective in Brazil even with a relatively low vaccine efficacy in seronegative individuals
São João del Rei has recorded another death from dengue fever - the second in 2016 so far.
Epidemiological bulletin showed the increase in the number of reported cases of dengue in Uberlândia. There were 1,862 new cases in three months.
Lessons learned in health communication and risk management of Chikungunya virus and other vector-born diseasesby Jair Vega et al.
Review of articles on communication strategies for vector-borne diseases
Outwitting dengue threat and epidemics resurgence in Asia-Pacific countries: strengthening integrated dengue surveillance, monitoring and response systemsby Tambo E et al.
Strengthening integrated dengue surveillance, monitoring and response systems
Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue in a Tertiary Hospital in Southern Indiaby Anand AM et al.
Evaluation of NS1 antigen assay as an alternative to RT-PCR for the early diagnosis of dengue
The Use of a Dengue Rapid Diagnostic Test During Suspected Dengue Outbreaks in Resource Limited Regionsby Hunsperger EA et al.
Evaluation of rapid diagnostic test for dengue virus
Analysis of potential dengue vaccine impact in Yucatán Mexico.
A study of dengue and yellow fever viruses in mosquitoes in Zaria, Nigeria
The growth of slums in the developing world's rapidly expanding cities is creating new opportunities for infectious disease to flourish and spread.
Estimating the public health importance of the CYD-tetravalent dengue vaccine: Vaccine preventable disease incidence and numbers needed to vaccinateby Bradford D. Gessner, Annelies Wilder-Smith
Vaccine efficacy alone is inadequate to capture the public health importance of vaccines.
An estimate of the global economic burden of dengue by country and super-region
This paper looks at the true cost of dengue fever
Real-time dengue surveillance is critical for identifying areas where transmission is ongoing or likely to occur so that interventions can be optimized. Sophisticated new tools can help - and so can you.
Secondary analysis of clinical trial data reveals dengue burden
Vector control, surveillance, drugs, diagnostics and vaccines all hold exciting potential but none can solve the problem alone. We need an integrated approach.
Suppression of the Arboviruses Dengue and Chikungunya Using a Dual-Acting Group-I Intron Coupled with Conditional Expression of the Bax C-Terminal Domainby James R. Carter, Samantha Taylor, Tresa S. Fraser, Cheryl A. Kucharski, James L. Dawson, Malcolm J.
Research points to a promising single antiviral for the transgenic suppression of multiple arboviruses
Scientists belive a protein may be key to new dengue drug discoveries?
The Zika virus is another wild card dealt to us by nature. It was first discovered in 1947.
With Zika infection rates now seeming to be on the increase, the Oxford Science Blog talked to Professor Lang about why it is so important to develop capacity for doing research in places where research doesn't normally happen.
In this seminar Professor Kevin Marsh describes how knowledge of immunity to malaria in humans has developed over the past thirty years and what impact this has for future research.
ABRAID, new website of infectious diseases risk maps